Could magnetic pulses ease cancer nerve pain?

NCT ID NCT07187219

Recruiting now Symptom relief Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a non-invasive brain stimulation technique called rTMS can reduce chronic nerve pain in people with cancer. Sixty participants will receive both real and sham (placebo) stimulation in a crossover design, with an 8-week break in between. The goal is to see if active rTMS provides more pain relief than placebo, and to measure effects on quality of life and mood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: repetitive transcranial magnetic stimulation (rTMS) device
What this could lead to: If it works, this could offer a non-drug option to reduce chronic nerve pain in cancer patients, improving quality of life.
What could go wrong: This is a small, early-stage study with only 60 people. The effect may be modest or no better than placebo, and results may not apply to all cancer pain types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER CHRONIC NEUROPATHIC PAIN

Contacts and locations

Locations

PEYRON Roland
RECRUITING

Saint-Etienne, 42055, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.